Melvin Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-790,956
Closed -$225M 10
2022
Q1
$225M Buy
790,956
+128,950
+19% +$36.6M 2.28% 21
2021
Q4
$249M Buy
662,006
+287,006
+77% +$108M 1.22% 32
2021
Q3
$155M Buy
+375,000
New +$155M 0.79% 39